2015-03-01
Are immune signatures a worthwhile tool for decision making in early-stage human epidermal growth factor receptor 2 - Positive breast cancer?
Publication
Publication
Journal of Clinical Oncology , Volume 33 - Issue 7 p. 673- 675
Additional Metadata | |
---|---|
doi.org/10.1200/JCO.2014.59.5058, hdl.handle.net/1765/87013 | |
Journal of Clinical Oncology | |
Organisation | Erasmus MC Cancer Institute |
Foekens, J., Martens, J. W. M., & Sleijfer, S. (2015). Are immune signatures a worthwhile tool for decision making in early-stage human epidermal growth factor receptor 2 - Positive breast cancer?. Journal of Clinical Oncology, 33(7), 673–675. doi:10.1200/JCO.2014.59.5058 |